SMS PHARMACEUTICALS
Back to Balance Sheet
|
SMS PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹43 Cr | ₹41 Cr | ₹40 Cr | ₹54 Cr | ₹40 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SMS PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2024 | ₹43 Cr |
Mar2023 | ₹41 Cr |
Mar2022 | ₹40 Cr |
Mar2021 | ₹54 Cr |
Mar2020 | ₹40 Cr |
How is Deferred Tax Assets / Liabilities of SMS PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹43 Cr | 4.34 | |
Mar2023 | ₹41 Cr | 3.71 | |
Mar2022 | ₹40 Cr | -26.56 | |
Mar2021 | ₹54 Cr | 35.50 | |
Mar2020 | ₹40 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of SMS PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
SMS PHARMACEUTICALS | ₹1,682.6 Cr | -6% | -10.3% | 40.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,003.0 Cr | -1.6% | -4.6% | 14.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹154,939.0 Cr | -1.6% | -1.3% | 61.6% | Stock Analytics | |
CIPLA | ₹117,835.0 Cr | 0.1% | 1.2% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹99,784.6 Cr | -2.1% | -8.7% | -2.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹90,722.1 Cr | -6.5% | -9.3% | 8.6% | Stock Analytics |
SMS PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
SMS PHARMACEUTICALS | -6% |
-10.3% |
40.8% |
SENSEX | -2.5% |
-1.4% |
6.1% |
You may also like the below Video Courses